Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Arrowroot Family Office LLC

Arrowroot Family Office LLC decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 41.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,396 shares of the biotechnology company’s stock after selling 972 shares during the period. Arrowroot Family Office LLC’s holdings in Axon Enterprise were worth $558,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blue Trust Inc. increased its position in Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after acquiring an additional 79 shares during the period. Quent Capital LLC raised its stake in shares of Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares during the last quarter. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise during the third quarter worth $41,000. Asset Dedication LLC purchased a new position in Axon Enterprise in the 2nd quarter valued at $47,000. Finally, Planning Capital Management Corp increased its stake in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 55 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on AXON. JMP Securities lifted their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Barclays boosted their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird increased their price objective on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, Craig Hallum boosted their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $427.83.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 75,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the sale, the chief executive officer now owns 2,970,366 shares in the company, valued at approximately $1,059,024,589.98. This trade represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the sale, the president now directly owns 208,166 shares of the company’s stock, valued at $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 210,256 shares of company stock valued at $87,783,120. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 1.9 %

Shares of AXON opened at $646.96 on Monday. Axon Enterprise, Inc. has a 1-year low of $224.28 and a 1-year high of $652.22. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a 50 day simple moving average of $488.25 and a 200-day simple moving average of $379.59. The stock has a market cap of $49.33 billion, a price-to-earnings ratio of 167.17, a price-to-earnings-growth ratio of 14.24 and a beta of 0.94.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.